Biopharmaceutical innovation and oncology therapeutics by Zymeworks (ZYME)

  • Mykhailo Ihnatenko
  • 04.11.2026
Zymeworks will present preclinical data on ZW1953 after stock ends session up 4.1%
Zymeworks will present preclinical data on its new CD3 multispecific T cell engager, ZW1953, at the 2026 American Society of Hematology Annual Meeting. The stock is up 4.1% on the day at ...
  • Mykhailo Ihnatenko
  • 23.10.2026
Zymeworks enters global license agreement with Roche for ZW209 after stock ends session up 1%
Zymeworks has entered into an exclusive global licensing agreement with Roche for a next-generation cancer therapy that could bring the company up to $813 million in payments, milestones, and ...
  • Ezequiel Gomes
  • 01.08.2026
Zymeworks stock under pressure with downside momentum and oversold signals intensifying
Zymeworks marked Lung Cancer Awareness Day by recognizing the millions of people affected by lung cancer.The company stated its commitment to advancing next-generation therapeutics designed to ...
  • Sholanke Dele
  • 31.07.2026
Zymeworks Inc slides slightly amid continued resistance near $24.40 and mixed technical signals
Zymeworks has recently shared new insights into its research and development efforts. The company communicated this update in a tweet.Zymeworks pointed to highlights such as its presentation ...
  • Sholanke Dele
  • 29.07.2026
Zymeworks stock extends weekly losses to trade near $22.61 support as momentum stays weak
Zymeworks hosted its annual employee patio party as part of its ongoing summer traditions. The IT and HR teams co-hosted this year's Summer Bytes event in Vancouver.A different team takes the lead ...
  • Ashutosh Sureka
  • 04.07.2026
Zymeworks Inc stock consolidates near 52-week highs after strong weekly rally
Zymeworks recognized Independence Day and extended well wishes to colleagues, collaborators, and communities across the United States.The company wished everyone celebrating a safe and enjoyable ...
  • Dan Blystone
  • 01.07.2026
Zymeworks Inc celebrates Canada Day as Zymeworks stock slips 2.94% after strong weekly gains
Zymeworks marked Canada Day by celebrating its Canadian roots and the people who contribute to its scientific progress. The company stated this in a message on Monday.Zymeworks said its ...
  • Jose Antonio Gastelum
  • 29.06.2026
Zymeworks stock rises after $929 million Theravance Biopharma acquisition agreement
Zymeworks announced it has entered into a definitive agreement to acquire Theravance Biopharma for approximately US$929 million.The proposed acquisition would add commercial and development-stage ...
  • Ezequiel Gomes
  • 19.06.2026
Zymeworks Inc trades in narrow range near $23 as sideways momentum persists
Zymeworks recognized Juneteenth as the oldest nationally celebrated commemoration marking the end of slavery in the United States.The company stated its commitment to honoring the ongoing pursuit ...
  • Ciaran Ryan
  • 07.06.2026
Zymeworks stock drops 4.22% as Zymeworks Inc posts National Cancer Survivors Day tribute
Zymeworks recognized and celebrated National Cancer Survivors Day, acknowledging the strength and resilience of cancer survivors. The company marked the occasion publicly.Zymeworks stated that ...
  • Sholanke Dele
  • 02.06.2026
Zymeworks stock edges lower with short-term pressure despite event participation
Zymeworks will participate in the Jefferies Global Healthcare Conference in New York this week.Management is scheduled to join a fireside chat on June 3 at 8:45 a.m. ET. The session will cover the ...